Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma

Autor: CJ de Boer, E Schuuring, E Dreef, G Peters, J Bartek, PM Kluin, JH van Krieken

Publikováno v: Blood. 86:2715-2723

Mantle cell lymphoma (MCL) is a clinicopathologic entity that is difficult to diagnose on histopathologic criteria. Approximately 50% to 70% of MCL contain a t(11;14)(q13;q32) translocation involving the cyclin D1 gene. Irrespective of this rearrange

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f27aed29cca3216f76e17ed9f4c6fa9
https://doi.org/10.1182/blood.v86.7.2715.bloodjournal8672715

Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas

Autor: JH van Krieken, M Raffeld, S Raghoebier, ES Jaffe, GJ van Ommen, PM Kluin

Publikováno v: Blood. 76(4)

Thirty-two extranodal lymphomas of the gastrointestinal (GI) tract underwent molecular genetic analysis by Southern blotting using probes for the immunoglobulin genes and the bcl-1, bcl-2, and c-myc loci, commonly involved in lymphomagenesis. No bcl-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417e629125e39161fa0bb6f939dc27cb
https://pubmed.ncbi.nlm.nih.gov/2200538

Consensus molecular subtype transition during progression of colorectal cancer.

Autor: van de Weerd S; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Torang A; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Zwager LW; Department of Gastroenterology and Hepatology, Amsterdam UMC, location AMC, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, The Netherlands., Koelink PJ; Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Koster J; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bastiaansen BA; Department of Gastroenterology and Hepatology, Amsterdam UMC, location AMC, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, The Netherlands., Lammers V; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Longobardi C; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Roodhart JM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Krieken JH; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands., Farina Sarasqueta A; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Dekker E; Department of Gastroenterology and Hepatology, Amsterdam UMC, location AMC, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, The Netherlands., Medema JP; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: The Journal of pathology [J Pathol] 2023 Nov; Vol. 261 (3), pp. 298-308. Date of Electronic Publication: 2023 Sep 08.

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.

Autor: Xu-Monette ZY; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina., Wei L; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Children's Hospital of Chongqing Medical University, Chongqing, China., Fang X; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Au Q; NeoGenomics Laboratories, Aliso Viejo, California., Nunns H; NeoGenomics Laboratories, Aliso Viejo, California., Nagy M; NeoGenomics Laboratories, Aliso Viejo, California., Tzankov A; Institute of Pathology, University Hospital Basel, Basel, Switzerland., Zhu F; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina., Visco C; University of Verona, Verona, Italy., Bhagat G; Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, New York., Dybkaer K; Aalborg University Hospital, Aalborg, Denmark., Chiu A; Mayo Clinic, Rochester, Minnesota., Tam W; Weill Medical College of Cornell University, New York, New York., Zu Y; The Methodist Hospital, Houston, Texas., Hsi ED; Cleveland Clinic, Cleveland, Ohio., Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sun X; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Han X; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Go H; Asan Medical Center, Ulsan University College of Medicine, Seoul, Republic of South Korea., Ponzoni M; San Raffaele H. Scientific Institute, Milan, Italy., Ferreri AJM; San Raffaele H. Scientific Institute, Milan, Italy., Møller MB; Odense University Hospital, Odense, Denmark., Parsons BM; Gundersen Lutheran Health System, La Crosse, Wisconsin., van Krieken JH; Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands., Piris MA; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Winter JN; Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Li Y; Department of Medicine, Baylor College of Medicine, Houston, Texas., Xu B; The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China., Albitar M; Genomic Testing Cooperative, LCA, Irvine, California., You H; Children's Hospital of Chongqing Medical University, Chongqing, China., Young KH; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Duke Cancer Institute, Durham, North Carolina.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 01; Vol. 28 (5), pp. 972-983.

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.

Autor: You H; Department of Hematology and Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA., Xu-Monette ZY; Department of Hematology and Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China., Wei L; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA.; Duke Cancer Institute, Durham, North Caronlina, USA., Nunns H; Duke Cancer Institute, Durham, North Caronlina, USA., Nagy ML; Duke Cancer Institute, Durham, North Caronlina, USA., Bhagat G; NeoGenomics Laboratories, Aliso Viejo, California, USA., Fang X; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA., Zhu F; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA., Visco C; Department of Pathology and Cell Biology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, New York, USA., Tzankov A; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Dybkaer K; Department of Pathology, Institute of Pathology,University Hospital Basel, Switzerland., Chiu A; Clinical Department, Aalborg University Hospital, Aalborg, Denmark., Tam W; Hematopathology Department, Mayo Clinic, Rochester, Minnesota, USA., Zu Y; Department of Pathology, Weill Medical College of Cornell University, New York, New York, USA., Hsi ED; Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas, USA., Hagemeister FB; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA., Huh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ponzoni M; Department of Pathology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea., Ferreri AJM; Department of Pathology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea., Møller MB; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Parsons BM; Department of Pathology, Odense University Hospital, Odense, Denmark., Van Krieken JH; Hematology & Oncology, Gundersen Lutheran Health System, La Crosse, Wisconsin, USA., Piris MA; Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands., Winter JN; Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Li Y; Department of Medicine (Hematology and Oncology), Feinberg School of Medicine, Northwestern University, Chicago, Illinois,USA., Au Q; Duke Cancer Institute, Durham, North Caronlina, USA., Xu B; Department of Medicine, Baylor College of Medicine, Houston, Texas,USA., Albitar M; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian,China., Young KH; Department of Hematology and Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.; Genomic Testing Cooperative, LCA, Irvine, California,USA.

Publikováno v: Oncoimmunology [Oncoimmunology] 2021 Jul 20; Vol. 10 (1), pp. 1928365. Date of Electronic Publication: 2021 Jul 20 (Print Publication: 2021).